The Journal of Urology® Manuscript Review is a comprehensive learning activity developed by a team of educators, academicians and clinicians. The clinical review of manuscripts being considered for publication in The Journal of Urology® provides another format of learning for clinical reviewers and ensures that the highest standards for evidence-based clinical content are met.
After completing this manuscript review, reviewers will be able to:
- Analyze the manuscript and other background material as required toward increased knowledge of the subject matter.
- Recognize opportunities to apply this increased knowledge of the subject matter in clinical practice.
- Appraise the manuscript for sound, evidence-based scientific principles that are generally accepted as valid by the medical profession.
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association designates this manuscript review activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Medium and Method of Participation for Credit
- The review of the manuscript will be graded on a scale of "1" to "5" with "1" being the best possible grade. Only reviews graded "1," "2," or "3" will be eligible for credit.
- The editor of The Journal of Urology® will assess the Manuscript Review Request for CME credit form, and approve or disapprove the request for credit.
- Manuscript Review Credits are limited to (5) five reviews or (15) fifteen AMA PRA Category 1 Credits™ per year.
AUA Disclosure Policy
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Conflict of Interest Review Work group or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Faculty & Planner Disclosures
Joseph A. Smith, Jr., MD
Editor, The Journal of Urology®
Department of Urology Surgery
Vanderbilt University Medical Center
Disclosures: Nothing to disclose
Victor Nitti, MD
Chair, Education Council, AUA Office of Education
Professor of Urology and OB/GYN
Vice Chairman, Department of Urology
Director of Female Pelvic Medicine and Reconstructive Surgery
NYU Langone Medical Center
New York, NY
Disclosures: Serenity Pharmaceuticals, Investment Interest
Evidence Based Content
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Off-label or Unapproved Use of Drugs or Devices
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.